v3.25.3
Equity
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Equity

Note 6. Equity

 

The Company is currently authorized to issue up to 200,000,000 shares of common stock with a par value of $0.0001. In addition, the Company is authorized to issue 20,000,000 shares of preferred stock with a par value of $0.0001. The specific rights of the preferred stock, when so designated, shall be determined by the board of directors.

 

Stock Warrants

 

The following table summarizes the stock warrant activity for the nine months ended September 30, 2025:

        
   Number of
Options		   Weighted Average Exercise Price Per Share 
         
Outstanding at December 31, 2024   1,000,000   $1.00 
Granted   –    – 
Exercised   –    – 
Forfeited and expired   –    – 
Outstanding at September 30, 2025   1,000,000   $1.00 

 

As of September 30, 2025, all outstanding warrants are exercisable and have a weighted average remaining term of 0.25 years. There was no intrinsic value of the outstanding warrants as of September 30, 2025.

 

Stock Options

 

The following table summarizes the stock option activity for the nine months ended September 30, 2025:

        
   Number of
Options		   Weighted Average Exercise Price Per Share 
         
Outstanding at December 31, 2024   10,350,000   $0.10 
Granted   –    – 
Exercised   –    – 
Forfeited and expired   –    – 
Outstanding at September 30, 2025   10,350,000   $0.10 

  

During the nine months ended September 30, 2025, the Company recognized $228,144 of expense related to outstanding stock options leaving $262,697 of unrecognized expenses related to options. As of September 30, 2025, the outstanding stock options have a weighted average remaining term of 7.34 years with no aggregate intrinsic value.